FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure - Quiz - MDSpire

FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

Phase 3 data showed a 67% reduction in symptomatic infection among exposed household contacts who tested negative at baseline.

Share

Conexiant

Conexiant

Label change follows completion of required pediatric evaluation and updates prior age restrictions for treatment eligibility.

Conexiant

These 10 states report physician shortages, projected physician supply gaps, or physician-to-population ratios below national benchmarks.

Conexiant

Recommendations outline splinting, replantation timing, imaging, and long-term surveillance strategies for permanent tooth injuries.